Literature DB >> 20042333

Benzimidazole- and indole-substituted 1,3'-bipyrrolidine benzamides as histamine H3 receptor antagonists.

Derek C Cole1, Jonathan L Gross, Thomas A Comery, Suzan Aschmies, Warren D Hirst, Cody Kelley, Ji-In Kim, Katie Kubek, Xiaoping Ning, Brian J Platt, Albert J Robichaud, William R Solvibile, Joseph R Stock, Gregory Tawa, Marla J Williams, John W Ellingboe.   

Abstract

Using a focused screen of biogenic amine compounds we identified a novel series of H(3)R antagonists. A preliminary SAR study led to reduction of MW while increasing binding affinity and potency. Optimization of the physical properties of the series led to (S)-6n, with improved brain to plasma exposure and efficacy in both water intake and novel object recognition models. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20042333     DOI: 10.1016/j.bmcl.2009.11.122

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Assessment of [125I]WYE-230949 as a novel histamine H3 receptor radiopharmaceutical.

Authors:  David Y Lewis; Sue Champion; David Wyper; Deborah Dewar; Sally Pimlott
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

2.  Design, synthesis, bio-evaluation, and in silico studies of some N-substituted 6-(chloro/nitro)-1H-benzimidazole derivatives as antimicrobial and anticancer agents.

Authors:  Em Canh Pham; Tuong Vi Thi Le; Tuyen Ngoc Truong
Journal:  RSC Adv       Date:  2022-08-03       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.